Cenegermin, The placebo for investigational lyophilized cenegermin Drug Product is the same as the Drug Product with the exception that it does not contain cenegermin.
NGF-CP-201
Phase 2 small_molecule active
Quick answer
Cenegermin, The placebo for investigational lyophilized cenegermin Drug Product is the same as the Drug Product with the exception that it does not contain cenegermin. for Spastic Cerebral Palsy is a Phase 2 program (small_molecule) at Dompe' Farmaceutici S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Dompe' Farmaceutici S.p.A.
- Indication
- Spastic Cerebral Palsy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active